Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.
about
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysisRacial, social, and clinical determinants of hepatocellular carcinoma surveillancePractice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.Surveillance and Diagnosis of Hepatocellular Carcinoma.Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States.The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapyThe effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.Screening process failures for hepatocellular carcinoma.Diagnostic delays are common among patients with hepatocellular carcinoma.Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
P2860
Q21144594-880AC13E-C28D-4C3B-BC18-C132053D837AQ34808945-79DACC4A-3A2A-4D7D-9CBF-42DE880AA580Q34902635-D4647DBB-934C-41BF-8E98-9524BC75594CQ36199751-6E33A10F-B3B2-4EDF-A524-9DDBEFAE79C6Q36812480-BF1837DF-C7EC-45D5-8762-78D2628C8A8CQ36871021-0AA0B290-EC81-4F4D-9813-9D5512AB2057Q37184472-57B1F3DC-D800-406B-9985-CFBBEC7A1404Q37606028-168B1439-21D5-49C6-996F-7E3C70B50602Q38180333-6612CB31-9D9C-4E50-81AE-9EB3F6DBDC1BQ39483593-417F3190-BB22-4ED4-B7CB-A9733B1EEA19Q40136684-5C84B76D-1B8F-4B74-AF38-A4B62815D2C1Q40176654-E3156F67-A55E-4C45-83B8-A75E95E42BFAQ40279432-2A7EA76C-2ED8-47E5-BCE8-AD4ED4B8B0DFQ40442376-C741AC91-50E9-47F4-B60F-DDF67A36E269Q41446019-5EE7A81D-528E-4A16-9F84-0000307CE221Q41482573-9B52C791-ABEC-4F00-826B-96B4FA8117C5Q48744867-8F7F7192-0EAE-4613-9911-69D7F803A39FQ50599978-A29573B0-84E4-498B-97E0-41008DFC64F3Q53060409-0E5BB48F-6E91-4914-B92F-7DC861C1C77F
P2860
Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Improving hepatocellular carci ...... m colorectal cancer screening.
@ast
Improving hepatocellular carci ...... m colorectal cancer screening.
@en
type
label
Improving hepatocellular carci ...... m colorectal cancer screening.
@ast
Improving hepatocellular carci ...... m colorectal cancer screening.
@en
prefLabel
Improving hepatocellular carci ...... m colorectal cancer screening.
@ast
Improving hepatocellular carci ...... m colorectal cancer screening.
@en
P2860
P1476
Improving hepatocellular carci ...... om colorectal cancer screening
@en
P2093
Amit G Singal
Samir Gupta
P2860
P304
P356
10.1016/J.CGH.2012.11.010
P407
P50
P577
2012-11-28T00:00:00Z